148 related articles for article (PubMed ID: 19070399)
1. Disseminated intravascular coagulation (DIC) and non-small cell lung cancer (NSCLC): report of a case and review of the literature.
Voulgaris E; Pentheroudakis G; Vassou A; Pavlidis N
Lung Cancer; 2009 May; 64(2):247-9. PubMed ID: 19070399
[TBL] [Abstract][Full Text] [Related]
2. Fatal acute disseminated intravascular coagulation as presentation of advanced ALK-positive non-small cell lung cancer: Does oncogene addiction matter?
De Giglio A; Porreca R; Brambilla M; Metro G; Prosperi E; Bellezza G; Pirro M; Chiari R; Ricciuti B
Thromb Res; 2018 Mar; 163():51-53. PubMed ID: 29353684
[No Abstract] [Full Text] [Related]
3. Nonpalpable purpura within a setting of anticoagulant therapy and metastatic carcinoma.
Grenier N; Chen-Tsai C
Int J Low Extrem Wounds; 2006 Sep; 5(3):200-3. PubMed ID: 16928675
[TBL] [Abstract][Full Text] [Related]
4. [Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case].
Deme D; Ragán M; Kalmár K; Kovács L; Varga E; Varga T; Rakonczai E
Magy Onkol; 2010 Dec; 54(4):351-7. PubMed ID: 21163766
[TBL] [Abstract][Full Text] [Related]
5. Gefitinib-induced disseminated intravascular coagulation in a patient with non-small cell lung cancer.
Yuan GJ; Ke QH; Xu XM; Yang JY; Su XY
Chin Med J (Engl); 2010 Feb; 123(4):505-6. PubMed ID: 20193495
[No Abstract] [Full Text] [Related]
6. Resolution of thrombocytopenia secondary to disseminated intravascular coagulation with docetaxel chemotherapy in prostate cancer.
Talebi TN; Manoharan M; Singal R
Am J Ther; 2012 Jan; 19(1):e59-61. PubMed ID: 20535002
[TBL] [Abstract][Full Text] [Related]
7. Erlotinib-induced acute interstitial lung disease associated with extreme elevation of the plasma concentration in an elderly non-small-cell lung cancer patient.
Tsubata Y; Hamada A; Sutani A; Isobe T
J Cancer Res Ther; 2012; 8(1):154-6. PubMed ID: 22531540
[TBL] [Abstract][Full Text] [Related]
8. First-line therapy and methylation status of CHFR in serum influence outcome to chemotherapy versus EGFR tyrosine kinase inhibitors as second-line therapy in stage IV non-small-cell lung cancer patients.
Salazar F; Molina MA; Sanchez-Ronco M; Moran T; Ramirez JL; Sanchez JM; Stahel R; Garrido P; Cobo M; Isla D; Bertran-Alamillo J; Massuti B; Cardenal F; Manegold C; Lianes P; Trigo JM; Sanchez JJ; Taron M; Rosell R
Lung Cancer; 2011 Apr; 72(1):84-91. PubMed ID: 20705357
[TBL] [Abstract][Full Text] [Related]
9. Disseminated intravascular coagulation in a patient with metastatic prostate cancer: fatal outcome following strontium-89 therapy.
Leong C; McKenzie MR; Coupland DB; Gascoyne RD
J Nucl Med; 1994 Oct; 35(10):1662-4. PubMed ID: 7931669
[TBL] [Abstract][Full Text] [Related]
10. Clustered incidence of acute promyelocytic leukemia during gefitinib treatment for non-small-cell lung cancer: experience at a single institution.
Matsuo K; Kiura K; Tabata M; Uchida A; Hotta K; Niiya D; Kubonishi S; Ogino A; Fujiwara Y; Nakajima H; Shinagawa K; Ishimaru F; Ueoka H; Tanimoto M
Am J Hematol; 2006 May; 81(5):349-54. PubMed ID: 16628731
[TBL] [Abstract][Full Text] [Related]
11. Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21.
Bezjak A; Tu D; Seymour L; Clark G; Trajkovic A; Zukin M; Ayoub J; Lago S; de Albuquerque Ribeiro R; Gerogianni A; Cyjon A; Noble J; Laberge F; Chan RT; Fenton D; von Pawel J; Reck M; Shepherd FA;
J Clin Oncol; 2006 Aug; 24(24):3831-7. PubMed ID: 16921034
[TBL] [Abstract][Full Text] [Related]
12. Relationship between skin rash and outcome in non-small-cell lung cancer patients treated with anti-EGFR tyrosine kinase inhibitors: a literature-based meta-analysis of 24 trials.
Petrelli F; Borgonovo K; Cabiddu M; Lonati V; Barni S
Lung Cancer; 2012 Oct; 78(1):8-15. PubMed ID: 22795701
[TBL] [Abstract][Full Text] [Related]
13. Erlotinib in the treatment of non-small cell lung cancer: current status and future developments.
Gridelli C; Maione P; Bareschino MA; Schettino C; Sacco PC; Ambrosio R; Barbato V; Falanga M; Rossi A
Anticancer Res; 2010 Apr; 30(4):1301-10. PubMed ID: 20530444
[TBL] [Abstract][Full Text] [Related]
14. Disseminated intravascular coagulation in solid tumors: clinical and pathologic study.
Sallah S; Wan JY; Nguyen NP; Hanrahan LR; Sigounas G
Thromb Haemost; 2001 Sep; 86(3):828-33. PubMed ID: 11583315
[TBL] [Abstract][Full Text] [Related]
15. Gefitinib is also active for carcinomatous meningitis in NSCLC.
Kim MK; Lee KH; Lee JK; Choi JH; Hyun MS
Lung Cancer; 2005 Nov; 50(2):265-9. PubMed ID: 16024135
[TBL] [Abstract][Full Text] [Related]
16. Benefit in lung function improvement and side-effect profile of long-term responders: an analysis of 14 NSCLC patients treated for at least 9 months with gefitinib.
Reck M; Gatzemeier U
Lung Cancer; 2005 Oct; 50(1):107-14. PubMed ID: 15985306
[TBL] [Abstract][Full Text] [Related]
17. Disseminated intravascular coagulation at presentation of advanced gastric cancer.
Tokar M; Bobilev D; Ariad S; Geffen DB
Isr Med Assoc J; 2006 Dec; 8(12):853-5. PubMed ID: 17214103
[TBL] [Abstract][Full Text] [Related]
18. Erlotinib treatment for persistent spontaneous pneumothorax in non-small cell lung cancer: a case report.
Ren SX; Zhou SW; Zhang L; Zhou CC
Chin Med J (Engl); 2010 Dec; 123(23):3501-3. PubMed ID: 22166539
[No Abstract] [Full Text] [Related]
19. Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapy.
Kim ST; Uhm JE; Lee J; Sun JM; Sohn I; Kim SW; Jung SH; Park YH; Ahn JS; Park K; Ahn MJ
Lung Cancer; 2012 Jan; 75(1):82-8. PubMed ID: 21684626
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for disseminated intravascular coagulation in patients with lung cancer.
Nakano K; Sugiyama K; Satoh H; Shiromori S; Sugitate K; Arifuku H; Yoshida N; Watanabe H; Tokita S; Wakayama T; Tatewaki M; Souma R; Koyama K; Hirata H; Fukushima Y
Thorac Cancer; 2018 Aug; 9(8):931-938. PubMed ID: 29851300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
